118 related articles for article (PubMed ID: 23149178)
1. 0.5 mg/kg versus 1 mg/kg of intravenous omeprazole for the prophylaxis of gastrointestinal bleeding in critically ill children: a randomized study.
Solana MJ; López-Herce J; Sánchez A; Sánchez C; Urbano J; López D; Carrillo A
J Pediatr; 2013 Apr; 162(4):776-782.e1. PubMed ID: 23149178
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.
Conrad SA; Gabrielli A; Margolis B; Quartin A; Hata JS; Frank WO; Bagin RG; Rock JA; Hepburn B; Laine L
Crit Care Med; 2005 Apr; 33(4):760-5. PubMed ID: 15818102
[TBL] [Abstract][Full Text] [Related]
3. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
Osteyee JL; Banner W
Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
[TBL] [Abstract][Full Text] [Related]
4. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
5. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
Balaban DH; Duckworth CW; Peura DA
Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
[TBL] [Abstract][Full Text] [Related]
6. Failure of nasogastric omeprazole suspension in pediatric intensive care patients.
Haizlip JA; Lugo RA; Cash JJ; Vernon DD
Pediatr Crit Care Med; 2005 Mar; 6(2):182-7. PubMed ID: 15730606
[TBL] [Abstract][Full Text] [Related]
7. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
9. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
Ono S; Kato M; Ono Y; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
Endoscopy; 2009 Apr; 41(4):299-303. PubMed ID: 19340731
[TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic effects of intravenous omeprazole in critically ill children].
Solana MJ; López-Herce J; Botrán M; Urbano J; Del Castillo J; Garrido B
An Pediatr (Barc); 2013 Mar; 78(3):167-72. PubMed ID: 22818224
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.
Phillips JO; Metzler MH; Palmieri MT; Huckfeldt RE; Dahl NG
Crit Care Med; 1996 Nov; 24(11):1793-800. PubMed ID: 8917027
[TBL] [Abstract][Full Text] [Related]
12. Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
Kaufman SS; Lyden ER; Brown CR; Davis CK; Andersen DA; Olsen KM; Bergman KL; Horslen SP; Sudan DL; Fox IJ; Shaw BW; Langnas AN
J Pediatr Gastroenterol Nutr; 2002 Feb; 34(2):194-8. PubMed ID: 11840039
[TBL] [Abstract][Full Text] [Related]
13. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH.
Laterre PF; Horsmans Y
Crit Care Med; 2001 Oct; 29(10):1931-5. PubMed ID: 11588454
[TBL] [Abstract][Full Text] [Related]
14. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer.
Sheu BS; Chi CH; Yang HB; Jen CM; Lin XZ
Hepatogastroenterology; 1999; 46(28):2363-71. PubMed ID: 10521999
[TBL] [Abstract][Full Text] [Related]
15. Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.
Maton PN
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():45-52. PubMed ID: 16303037
[TBL] [Abstract][Full Text] [Related]
16. Role of intravenous omeprazole on non-variceal upper gastrointestinal bleeding after endoscopic treatment: a comparative study.
Këlliçi I; Kraja B; Mone I; Prifti S
Med Arh; 2010; 64(6):324-7. PubMed ID: 21218747
[TBL] [Abstract][Full Text] [Related]
17. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
18. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
[TBL] [Abstract][Full Text] [Related]
19. The potential clinical role of intravenous omeprazole.
Brunner GH; Thiesemann C
Digestion; 1992; 51 Suppl 1():17-20. PubMed ID: 1397742
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled study comparing omeprazole and cimetidine for the prophylaxis of stress-related upper gastrointestinal bleeding in patients with intracerebral hemorrhage.
Liu BL; Li B; Zhang X; Fei Z; Hu SJ; Lin W; Gao DK; Zhang L
J Neurosurg; 2013 Jan; 118(1):115-20. PubMed ID: 23061387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
